Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €59.43 EUR
Change Today +0.63 / 1.07%
Volume 135.0
As of 3:43 PM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for abbvie inc (4AB)

Year over year, AbbVie Inc. has seen their bottom line shrink from $4.1B USD to $1.8B USD despite an increase in revenues from $18.8B USD to $20.0B USD. An increase in the percentage of sales devoted to SGA costs from 27.06% to 28.07% was a key component in the falling bottom line in the face of rising revenues.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Reclassified
Dec 31
2013
Dec 31
2014
4 Year
Trend
Revenues17,444.018,380.018,790.019,960.0
TOTAL REVENUES17,444.018,380.018,790.019,960.0
Cost of Goods Sold4,597.04,508.04,581.04,389.0
GROSS PROFIT12,847.013,872.014,209.015,571.0
Selling General & Admin Expenses, Total4,345.04,668.05,085.05,602.0
R&D Expenses2,500.02,582.02,840.03,297.0
Other Operating Expenses------750.0
OTHER OPERATING EXPENSES, TOTAL6,845.07,250.07,925.09,649.0
OPERATING INCOME6,002.06,622.06,284.05,922.0
Interest Expense---104.0-299.0-429.0
Interest and Investment Income20.020.021.038.0
NET INTEREST EXPENSE20.0-84.0-278.0-391.0
Currency Exchange Gains (Loss)30.0-17.0-55.0-678.0
Other Non-Operating Income (Expenses)54.09.01.027.0
EBT, EXCLUDING UNUSUAL ITEMS6,106.06,530.05,952.04,880.0
Merger & Restructuring Charges-163.0-191.0-54.0-1,700.0
Other Unusual Items, Total-2,275.0-614.0-566.0-811.0
In Process R&D Expenses-673.0-288.0-338.0-352.0
Legal Settlements-1,500.0-100.0----
Other Unusual Items-56.0-213.0-228.0-422.0
EBT, INCLUDING UNUSUAL ITEMS3,668.05,725.05,332.02,369.0
Income Tax Expense235.0450.01,204.0595.0
Earnings from Continuing Operations3,433.05,275.04,128.01,774.0
NET INCOME3,433.05,275.04,128.01,774.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS3,433.05,275.04,102.01,765.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS3,433.05,275.04,102.01,765.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4AB:GR €59.43 EUR +0.63

4AB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $49.03 USD -0.31
Amgen Inc $163.58 USD -0.26
Bristol-Myers Squibb Co $68.30 USD -0.59
Eli Lilly & Co $74.30 USD +0.03
Medtronic PLC $77.82 USD -0.59
View Industry Companies
 

Industry Analysis

4AB

Industry Average

Valuation 4AB Industry Range
Price/Earnings 58.3x
Price/Sales 5.1x
Price/Book 75.8x
Price/Cash Flow 57.4x
TEV/Sales 4.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ABBVIE INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.